CXCR2 and neoplasm: We found no significant difference in the proliferation level between the AZD-5069 condition and DMSO vehicle control in the absence of dHL-60 cells (50% vs. 48%, p > 0.9999), meaning that CXCR2 inhibition alone did not affect the proliferation of tumor spheroids (Fig. 5a,b).